KLKelli Lehto

Kelli Lehto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kelli Lehto has a total of 798 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Polygenic contribution to cannabis use disorder shared with and independent of ADHD: a GWAS-by-subtraction approach

    by Marta Ribasés, Judit Cabana-Domínguez, Natalia Llonga, Silvia Alemany, Triinu Varvas, Laura Vilar-Ribó, Uxue Zubizarreta-Arruti, Pau Carabí-Gassol, Manuel D. Rodríguez-Romero, Valeria Macias-Chimborazo, et al.

    Cannabis use disorder (CUD) is a heterogeneous condition characterized by different patterns of comorbidity and clinical presentation, yet the genetic contributors to this heterogeneity remain poorly understood. CUD frequently co-occurs with attention-deficit/hyperactivity disorder (ADHD), reflecting, in part, their shared genetic liability. Distinguishing the genetic component of CUD that operates through ADHD from the component independent of ADHD may help clarify whether these two components differ in their association with substance-use phenotypes, psychiatric traits, and broader health outcomes. We applied genomic structural equation modeling–based GWAS-by-subtraction to large-scale ADHD and CUD genome-wide association studies to characterize these two CUD components and investigate their genetic and phenotypic association profiles. The ADHD-independent component accounted for approximately 35% of CUD SNP-based heritability and included three genome-wide significant loci. Although both components showed genetic correlations with substance dependence and risk-taking behaviors, they exhibited distinct patterns of genetic correlation with substance use phenotypes, other mental disorders, and health outcomes. In a phenome-wide association study of 114,410 Estonian Biobank participants, both genetic components were associated with multiple health conditions, but the ADHD-related genetic component generally showed larger effects. Across two clinical samples, polygenic score generated with both components further revealed distinct associations with the comorbidity between ADHD and substance use disorders (SUD). Both scores were associated with SUD among individuals without ADHD. In contrast, only the polygenic score for the ADHD-related component (PGSadhd) was associated with ADHD and comorbid ADHD and SUD, with the strongest association observed in the comorbid group. Mediation analysis further indicated that ADHD diagnosis accounted for approximately 20% of the association between PGSadhd and SUD. Together, these findings demonstrate that ADHD-related and ADHD-independent components of CUD have distinct genetic and phenotypic association profiles, suggesting that genetic heterogeneity may contribute to the clinical heterogeneity of SUD. This framework may help guide further research into the etiology and clinical presentation of the disorder.

  • Open Access

    Genomic meta-analyses of binge-eating behavior and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes

    by Jet D. Termorshuizen, Helena L. Davies, Sang-Hyuck Lee, Jessica K. Dennis, Christopher Hübel, Jessica S. Johnson, Yi Lu, Melissa A. Munn-Chernoff, Triinu Peters, Baiyu Qi, et al.

    Eating disorders—including anorexia nervosa (AN), bulimia nervosa and binge-eating disorder—are clinically distinct but exhibit symptom overlap and diagnostic crossover. Genomic analyses have mostly examined AN. Here we conducted a genomic meta-analysis of case–control studies of binge-eating behavior (BE; 39,279 cases, 1,227,436 controls), alongside analyses of AN (24,223 cases, 1,243,971 controls) and its subtypes (all European ancestries). We identified six BE-associated loci, including loci associated with a higher body mass index and impulse-control behaviors. AN genome-wide association studies yielded eight loci, validating six loci. Subsequent polygenic risk score analysis demonstrated an association with AN in two East Asian ancestry studies. BE and AN exhibited similar positive genetic correlations with psychiatric disorders but opposing genetic correlations with anthropometric traits. Most of the genetic signal in BE and AN was not shared with body mass index. We have extended eating disorder genomics beyond AN; future work will incorporate multiple diagnoses and global ancestries.


  • Open Access

    Psychiatric genetic liability is associated with the severity of COVID-19 and other acute respiratory infections: an observational study across five Northern European countries

    by Kadri Kõiv, Ragna Bugge Askeland, Lea Arregui Nordahl Christoffersen, Ingibjörg Magnúsdóttir, Daniel McCartney, Ole A. Andreassen, Thor Aspelund, Sofiya Babok, Mie Topholm Bruun, Archie Campbell, et al.

    Background: Pre-existing psychiatric disorders have been associated with the severity of acute respiratory infections, including COVID-19, particularly in hospitalized populations. However, the underlying mechanisms, especially in community-based populations, remain unknown, limiting preparedness for future pandemics. We investigated the role of genetic liability for psychiatric disorders and related traits in COVID-19 and other respiratory infection severity among individuals reporting SARS-CoV-2 testing and available respiratory symptom data. Methods: We included population-based cohort data from Denmark, Estonia, Iceland, Norway, and the United Kingdom (N = 78,507; 62% female; 41% SARS-CoV-2-positive; May 2020—March 2023). Respiratory infection severity was defined by self-reported days bedridden and an eleven-symptom composite score during the acute illness phase. Polygenic scores (PGSs) for eight psychiatric disorders and the personality trait neuroticism indexed genetic liability. Meta-analysed estimates from stepwise-adjusted regression analyses controlling for education, lifestyle, and psychiatric and somatic diagnosis history were used to assess associations between PGSs and acute respiratory infection severity, stratified by COVID-19 status. Results: Higher genetic liability to insomnia, major depression (MD), and neuroticism was consistently associated with longer time bedridden (relative risk ratios per 1 SD change in PGS: 1.07–1.14, 95% confidence intervals [CIs]: 1.03–1.21) and more symptoms (incident rate ratios [IRRs]: 1.02–1.04, 95% CIs: 1.01–1.05) due to COVID-19. PGSs for insomnia, MD, neuroticism, anxiety disorder, bipolar disorder, and schizophrenia were also linked to higher non-COVID-19 symptom count (IRRs: 1.01–1.05, 95% CIs: 1.00–1.07). These associations remained robust after adjustment for lifestyle, education and medical comorbidities. Individuals in the highest MD PGS decile reported 20% more symptoms in non-COVID-19 illness and 10% more in COVID-19 compared with the bottom decile. No consistent associations were detected with attention-deficit/hyperactivity disorder, alcohol dependence and post-traumatic stress disorder. No genetic link was observed with ischaemic heart disease or type 2 diabetes. Conclusions: Shared genetics may contribute to the link between psychiatric conditions and respiratory infection severity in community settings. Our results underscore the role of psychiatric genetic liability, beyond diagnosed psychiatric disorders, in contributing to both COVID-19 and other respiratory infection severity. These findings provide insights that may improve future risk stratification and public health strategies targeting respiratory viruses.


  • Open Access

    Atypical energy-related symptoms define biologically distinct subtypes of major depressive disorder

    by Arvid Harder, Rujia Wang, Jacob Bergstedt, Floris Huider, Siim Kurvits, Jackson Thorp, Tong Gong, Elham Assary, Anais B. Thijssen, Giuseppe Pierpaolo Merola, et al.

    Major depressive disorder (MDD) is a complex psychiatric disorder, characterized by a range of mood, cognitive, and neurovegetative symptoms. Current diagnostic criteria treat opposite symptom directions as equivalent; weight gain or loss, and increased or decreased sleep, each count toward a single diagnosis. We defined three subgroups of individuals meeting criteria for MDD: AERS+ (hypersomnia with increased appetite/weight gain), AERS- (insomnia with appetite/weight loss), and an Uncategorized group, and conducted genome-wide association meta-analyses for each (N_eff = 47,858, 156,624, and 215,828, respectively). We identified 27 genome-wide significant loci across subtypes, 4 for AERS+, 10 for AERS- and 13 for Uncategorized. AERS+ showed higher SNP-based heritability (10.9%) and lower polygenicity (1.7% of SNPs) than AERS- (7.9%; 2.9%) or Uncategorized (8.6%; 5.3%), with larger effect sizes at its associated loci. The AERS+ and AERS- subtypes were moderately genetically correlated (r_g= 0.64, se = 0.04). Metabolic traits emerged as a primary differentiator: AERS+ correlated positively with BMI, metabolic syndrome, and related traits, whereas AERS- correlated weakly in the opposite direction. These findings show that the directionality of neurovegetative symptoms indexes genetic heterogeneity within MDD, with metabolic biology as a central axis of differentiation.

  • Open Access

    Sex-specific associations between education-related genetic factors and fertility extend beyond educational attainment

    by Ivan A. Kuznetsov, Alexandros Giannelis, Estonian Biobank Research Team, Kelli Lehto, Triin Laisk, Cornelius A. Rietveld, Uku Vainik, Vasili Pankratov

    Population fertility patterns are closely linked to socioeconomic inequality, with educational attainment (EA) being a key predictor of completed fertility. While EA is partially heritable, the extent to which EA-associated genetic variation relates to fertility independently of education remains unclear, particularly outside Western European and North American populations. Using data from ~40,000 women and ~10,000 men in the Estonian Biobank, we examine sex-specific associations between EA polygenic scores (EA PGS) and completed fertility. We extend prior work by distinguishing cognitive and non-cognitive EA components, accounting for age at first pregnancy (AFP), and applying within-family analyses to assess the role of direct genetic effects. Among women, EA PGS is negatively associated with fertility, with a significantly stronger association for the non-cognitive than the cognitive EA polygenic score. The association between EA PGS and fertility is moderated by EA and changes sign across AFP strata, from negative among women with earlier AFP to positive among those with later AFP. Importantly, this association is not attenuated in within-family models, consistent with a predominant role of direct genetic effects. Among men, associations are weak or slightly positive and stable across education groups. Overall, EA-related genetic variation is associated with fertility through pathways that appear largely independent of educational attainment, suggesting that shared genetic influences operate through multiple mechanisms that differ by sex and reproductive timing.


  • Open Access

    Genetic influences on educational outcomes during and after the Soviet era: Revisiting evidence from Estonia

    by Ivan A. Kuznetsov, Margherita Malanchini, Oliver Pain, Jonathan Coleman, Philip S. Dale, Jean-Baptiste Pingault, Kathleen Rastle, Peeter Hõrak, Robert Plomin, Andres Metspalu, et al.

    The origins of individual differences in socioeconomic outcomes, including educational attainment and occupational status, reflect a combination of genetic and environmental factors whose relative contributions may shift across historical and societal contexts. Previous research suggested a doubling of genetic influence on these traits in independent Estonia compared to the Soviet era. Using the Estonian Biobank, now tenfold larger compared to the original study, we aimed to replicate and extend these findings. We found only limited evidence for the increase in genetic influence on social outcomes in independent Estonia with results differing between analytical setups. Most importantly, we show that genetic contribution to socioeconomic outcomes, as well as to height and body mass index, varies within each historical cohort depending on birth year and recruitment strategy. This highlights the limitations of generalising from the study cohort due to various participation biases and potential heterogeneity of social environment in both historical periods.


  • Open Access

    Assessing the overlap of personality traits and internalizing psychopathology using multi-informant data: Two sides of the same coin?

    by Helo Liis Soodla, Kelli Lehto, Kadri Kõiv, Uku Vainik, Kirsti Akkermann, René Mõttus

    Personality and psychopathology share a hierarchical dimensional structure, developmental trajectories and correlations with varied outcomes. However, quantifying the extent and details of their direct empirical overlap has been hindered by overreliance on self-reports and broad construct domains. Using multimethod data, we estimated the Big Five personality domains' and nuances' (items') "true" correlations (rtrue) with, and true predictive accuracy (rtruePRED) for, various psychopathology state domains, free of single-method and occasion-specific biases, random error, and direct content overlap. Our sample included Estonian Biobank participants (N = 16,226) who completed psychopathology and comprehensive personality questionnaires, and whose personality traits were also rated by close informants. Personality nuances out-predicted the Big Five domains for psychopathology, with items' rtruePRED = .31 … .58 for specific psychopathology domains of distress, fear, inattention, hyperactivity, insomnia, and fatigue, and rtruePRED = .52 for the general p factor. Individual items had various meaningful rtrues with the psychopathology domains. Among the Big Five, neuroticism was the strongest correlate of distress (rtrue = .29) and fear (rtrue = .13), while inattention was most correlated with conscientiousness (rtrue = -.56), hyperactivity with extraversion (rtrue = .25), fatigue with openness (rtrue = .12), and insomnia with conscientiousness (rtrue = .12). Associations based on self-reports alone were weaker. We argue for multirater and finer grained assessments of both personality and psychopathology to fully reveal the extent and details of their overlap. This association is likely stronger than typical self-report data suggest, yet psychopathology is not empirically redundant with personality traits. (PsycInfo Database Record (c) 2025 APA, all rights reserved).


  • Open Access

    Associations of Genetic Liability to Six Psychiatric Disorders With Cardiometabolic Diseases

    by Jacob Bergstedt, Kadri Kõiv, Andreas Jangmo, Marit Haram, Piotr P. Jaholkowski, Jorien L. Treur, Isabell Brikell, Zheng Chang, Henrik Larsson, Patrik K. E. Magnusson, et al.

    IMPORTANCE: Individuals with psychiatric disorders have increased risk of cardiometabolic diseases (CMDs). Evaluating how psychiatric genetic liability relates to CMD may clarify mechanisms. OBJECTIVE: Identify genetic overlap between psychiatric disorders and CMDs independent of cross-disorder pleiotropy, BMI, and smoking. DESIGN, SETTING, AND PARTICIPANTS: Three Northern European cohorts (the Swedish Twin Registry, the Estonian Biobank, and the Norwegian Mother, Father and Child Cohort Study [MoBa]) totaling 355,159 individuals. Associations with CMDs were estimated as adjusted odds ratios (AORs) from logistic models mutually adjusted for all psychiatric PRSs and in models additionally adjusting for body mass index (BMI) and smoking. Cohort-specific AORs were pooled by inverse-variance weighting. MAIN OUTCOMES AND MEASURES: Exposures were PRSs for attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), anxiety disorder, posttraumatic stress disorder (PTSD), bipolar disorder, and schizophrenia. Outcomes were diagnoses of CMDs (hyperlipidemia, obesity, type 2 diabetes, hypertensive diseases, arteriosclerosis, ischemic heart disease, heart failure, thromboembolic disease, cerebrovascular disease, and arrhythmias), ascertained from electronic health records. RESULTS: The MDD PRS was associated with increased risk of all CMDs across analyses (AORs ranged from 1.13 [95% CI, 1.10-1.15] for heart failure to 1.02 [95% CI, 1.00-1.05] for arrhythmias). The ADHD PRS was associated with increased risk of all CMDs (AOR ranged from 1.11 [95% CI, 1.09-1.12] for obesity to 1.02 [95% CI, 1.01-1.03] for hyperlipidemia), however associations where attenuated when adjusting for BMI and smoking (lifestyle adjusted AOR for obesity: 1.03 [95% CI, 1.02-1.05]). When not mutually adjusting for all psychiatric PRSs, anxiety disorder and PTSD PRSs were associated with all CMDs; these associations diminished after adjustment. The bipolar and schizophrenia PRSs were inversely associated with most CMDs (AOR for schizophrenia PRS and obesity, 0.93 [95% CI, 0.92-0.94]). CONCLUSIONS AND RELEVANCE: Associations between psychiatric PRSs and CMDs diverged: ADHD, MDD, anxiety disorder, and PTSD PRSs were positively associated with CMDs, whereas bipolar and schizophrenia PRSs were inversely associated. Genetic liability to MDD showed robust associations with CMDs independent of cross-disorder pleiotropy, BMI, and smoking status, whereas associations between the ADHD PRS and CMDs were largely attenuated after adjustment for BMI and smoking. Key Points: Question: Is genetic liability to specific psychiatric disorders associated with an increased risk of clinically diagnosed cardiometabolic diseases even after adjusting for cross-disorder psychiatric pleiotropy, body mass index, and smoking status? Findings: In this study of cohorts in Sweden, Estonia, and Norway, genetic liability to major depressive disorder (MDD) showed stronger associations with cardiometabolic disease (CMD) compared to other psychiatric disorders. Genetic liability to anxiety disorder and PTSD showed associations with CMD that were attenuated when adjusting for cross-disorder psychiatric pleiotropy. Genetic liability to ADHD showed strong associations with obesity and type 2 diabetes that were strongly attenuated when adjusting for body mass index, and smoking status. Genetic liability to schizophrenia showed inverse associations with CMD. Meaning: These findings suggest that MDD has a distinctive genetic relationship with CMD compared to other psychiatric disorders and that the well-established phenotypic association between schizophrenia and CMD is not related to genetic factors.


  • Open Access

    Genome-wide association studies of binge-eating behaviour and anorexia nervosa yield insights into the unique and shared biology of eating disorder phenotypes

    by Jet D Termorshuizen, Helena L Davies, Sang-Hyuck Lee, Jessica K Dennis, Christopher Hübel, Jessica S Johnson, Yi Lu, Melissa A Munn-Chernoff, Triinu Peters, Baiyu Qi, et al.

    Eating disorders—including anorexia nervosa (AN), bulimia nervosa, and binge eating disorder—are clinically distinct but exhibit symptom overlap and diagnostic crossover. Genomic analyses have mostly examined AN. We conducted the first genomic meta-analysis of binge-eating behaviour (BE; 39,279 cases, 1,227,436 controls), alongside new analyses of AN (24,223 cases, 1,243,971 controls) and its subtypes (all European ancestries). We identified six loci associated with BE, including loci associated with higher body mass index (BMI) and impulse-control behaviours. AN GWAS yielded eight loci, validating six loci. Subsequent polygenic risk score analysis demonstrated an association with AN in two East Asian ancestry cohorts. BE and AN exhibited similar positive genetic correlations with psychiatric disorders, but opposing genetic correlations with anthropometric traits. Most of the genetic signal in BE and AN was not shared with BMI. We have extended eating disorder genomics beyond AN; future work will incorporate multiple diagnoses and global ancestries.


  • Open Access

    Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia

    by Marco Solmi, Giovanni Croatto, Nicholas Fabiano, Stanley Wong, Arnav Gupta, Michele Fornaro, Lynne Kolton Schneider, S. Christy Rohani-Montez, Leanne Fairley, Nathalie Smith, et al.